High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and Acute Kidney Injury
Condition: HypercholesterolemiaInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Atorvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and Acute Kidney Injury
Condition: HypercholesterolemiaInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Atorvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and Acute Kidney Injury
Condition: HypercholesterolemiaInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Atorvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and Acute Kidney Injury
Condition: HypercholesterolemiaInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Atorvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and Acute Kidney Injury
Condition: HypercholesterolemiaInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Atorvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
High Potency Statins and the Risk of Diabetes
Conditions: Diabetes Mellitus, Type 2; Cardiovascular DiseaseInterventions: Drug: Rosuvastatin (≥10 mg); Drug: Atorvastatin (≥20 mg); Drug: Simvastatin (≥40 mg); Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin; Drug: Rosuvastatin ( (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials
A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1Interventions: Drug: Lovastatin ™; Device: placeboSponsors: University of Alabama at Birmingham; Children's Hospital Boston; Children's Hospital of Philadelphia; Children's Research Institute; Children's Hospital Medical Center, Cincinnati; National Cancer Institute (NCI); University of Chicago; University of Utah; Washington University School of Medicine; The Children's Hospital at Westmead; University of Texas Southwestern Medical CenterActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2009 Category: Research Source Type: clinical trials
Evaluation of Lovastatin in Severe Persistent Asthma
Condition: Severe Persistent AsthmaInterventions: Drug: Lovastatin; Drug: PlaceboSponsors: University of Chicago; University of ChicagoWithdrawn - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2008 Category: Research Source Type: clinical trials
